TABLE 2.
Straina | Mutation site (base no.) | Nucleotide change | Amino acid change | MIC (μg/ml)b
|
|
---|---|---|---|---|---|
CAP | VIO | ||||
H37Rvc | |||||
C-201 | 758 | ΔC | Frameshift | 40 | 20 |
C-202 | 7 | C→T | Arg 3 Stop | 40 | 20 |
C-203 | 397 | C insertion | Frameshift | 40 | 20 |
C-206 | 555 | T→G | Phe 185→Leu | ||
C-210 | 353 | T→C | Leu 118 Pro | 40 | 40 |
C-211 | 64 | C→T | Gln 22 Stop | ||
C-212 | 52 | C→T | Arg 18 Stop | ||
C-213 | 383 | T→A | Val 128 Glu | ||
C-214 | 26 | ΔC | Frameshift | ||
C-215 | 200 | C→A | Ala 67 Glu | ||
C-216 | None | N/A | N/A | ||
CDC1551c | |||||
C-302 | 550 | C→T | Gln 184 Stop | ||
C-307 | 64 | C→T | Gln 22 Stop | ||
C-308 | 586 | ΔG | Frameshift | 40 | 20 |
C-309 | 550 | C→A | Gln 184→Lys | ||
C-310 | 653 | ΔT | Frameshift | ||
C-311 | 550 | C→T | Gln 184 Stop | ||
C-312 | 64 | C→T | Gln 22 Stop | 40 | ≤10 |
C-313 | 310 | ΔG | Frameshift | ||
C-314 | 205 | A→G | Lys69→Glu | ||
C-315 | 548 | C→T | Pro183→Leu | 40 | 20 |
C-316 | 400 | ΔA | Frameshift | ||
Beijing Fc | |||||
C-501 | 272 | C→A | Ala91→Glu | 40 | ≤10 |
C-502 | 712 | G→A | Glu238→Lys | ||
C-503 | 673-674 | ΔGΔT | Frameshift | ||
C-504 | 550 | C→T | Gln 184 Stop | 40 | ≤10 |
C-505 | 477 | ΔG | Frameshift | 40 | ≤10 |
C-507 | 550 | C→T | Gln 184 Stop | ||
C-509 | 550 | C→T | Gln 184 Stop | ||
C-510 | None | N/A | N/A |
Mutants were selected on 7H10 containing 10μg of capreomycin/ml.
MICs were determined for a missense, nonsense, and frameshift mutant from each of the three different parent strains.
All parent strains were susceptible to 10 μg of capreomycin/ml and 10 μg of viomycin/ml. CAP, capreomycin; VIO, viomycin; N/A, not applicable.